Chiasma

Chiasma Applies Its Proprietary Technology to Approved Drugs, Converting Injectable Doses into Oral Formulations to Enhance Absorption. The Company’s Transient Permeability Enhancement (TPE) Technology Facilitates Drug Delivery to the Gastrointestinal Wall and From There to the Liver. It Is Suitable for Large Molecules That Have Only Been Administerable via Injection Until Now. TPE Can Also Be Used for Small Molecules That Are Already Orally Administered but Poorly Absorbed.